Application of cistanche salsa extract in preparing medicament for treating parkinsonism
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of Parkinson's disease and Cistanche, applied in the field of Cistanche extract, can solve problems such as undiscovered and delayed disease progression
Inactive Publication Date: 2008-10-29
ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF1 Cites 11 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The neuroprotective drugs that once aroused great hopes, such as slangiline, have not been f
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0028] Made into tablets, pills, granules, syrups, ointments. In addition to the total glycosides of Cistanche deserticola, flavoring agents can be added as required. The ingredients of the tablets, pills, granules, syrups and ointments include:
[0029] Cistanche total glycosides 5%-90% (weight ratio)
[0030] Flavoring agent 0.1-1% (weight ratio)
[0031] The above-mentioned flavoring agent can be selected from α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), N-LOK modified starch, sucrose, xylitol, high fructose, cyclamate, stevia and One or more of proteoglycans.
Embodiment 2
[0032] Embodiment 2 is made into capsules. The capsules consist of:
[0033] Cistanche total glycosides 15%-30% (by weight)
[0034] Flavoring agent 0.5-10% (weight ratio)
[0035] The above-mentioned corrective agents mainly include: hydroxypropyl methylcellulose (HPMC), polyethylene glycol (PEG), acrylic resin, etc.
Embodiment 3
[0036] Embodiment 3 is made injection, dropping pill. The injection and drop pills include:
[0037] Cistanche total glycosides 20%-30% (by weight)
[0038] Solvent amount
[0039] 4. Mechanism of treatment
[0040] Therapeutic mechanism of Cistanche deserticola extract in the preparation of medicament for treating Parkinson's disease
[0041] Contemporary TCM scholars usually use the traditional method of "syndrome differentiation and seeking cause" to deduce the TCM mechanism of Parkinson's disease. Most scholars believe that the pathogenesis of Parkinson's disease is characterized by deficiency in origin and excess in superficiality. There are many reasons for this deficiency, and the most important ones are roughly as follows: (1) age factor: Parkinson's disease is more common in the elderly, and Zhou's [1，2] It is believed that after middle age, when the yin qi is self-half, there will be physiological weakness such as liver and kidney deficiency, combined with fatig...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Diameter
aaaaa
aaaaa
Diameter
aaaaa
aaaaa
Login to view more
Abstract
The invention relates to the application of total cistanchis glycosides extracted from desertliving cistanche in the preparation of medicaments for treating Parkinson disease. Extract of the desertliving cistanche is prepared by the following method: 70 percent of ethanol is used for twice reflux after the desertliving cistanche is sliced, supernatant extraction is carried out, extract liquid is carried out the water floatation, thus obtaining supernatant liquid; the supernatant liquid passes through a macroporous resin, water is firstly used for elution, methanol is then used for elution, wherein, after using the methanol for elution, the solution is evaporated, after the evaporation, the products are dissolved by using n-butyl alcohol, thus obtaining water phase and alcohol phase; the alcohol phase is evaporated and then anhydrous ethanol is used for refining, thus obtaining the total cistanchis glycosides, which are the extract of the desertliving cistanche. The total cistanchis glycosides extracted from desertliving cistanche are used for the preparation of the medicaments for the treatment of Parkinson disease and can effectively improve the motion function of the patients with the Parkinson disease, slow the progress in the course of the Parkinson disease and bring a new hope for the treatment of the Parkinson disease by using traditional Chinese medicine.
Description
technical field [0001] The present invention relates to the application of the extract of Cistanche deserticola, in particular to the new application of the extract of Cistanche deserticola in pharmacy. Background technique [0002] Herba Cistanchis (Herba Cistanchis) is a plant of the genus Cistanchis in the family of Danaceae. It was first recorded in "Shen Nong's Materia Medica", and it is a commonly used variety in TCM tonic medicines. Cistanche Herba Cistanche Indications: impotence due to kidney deficiency, nocturnal emission and premature ejaculation, female infertility, weakness of muscles and bones due to liver and kidney deficiency, cold pain in the waist and knees after senile illness, postpartum, insufficient body fluid, intestinal dryness and constipation. At present, total glycosides of Cistanche deserticola (components of phenylethanol glycosides, also known as total glycosides of Cistanche deserticola) are extracted from Cistanche deserticola. The commercial...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more